miércoles, 19 de septiembre de 2012

Call for Applications: NCI Clinical Assay Development Program ► NCI Cancer Bulletin for September 18, 2012 - National Cancer Institute

NCI Cancer Bulletin for September 18, 2012 - National Cancer Institute





Call for Applications: NCI Clinical Assay Development Program


The NCI Clinical Assay Development Program (CADP) is requesting project applications from investigators seeking resources for clinical assay validation. These resources are designed to assist with the development of assays that may predict therapy response or prognostic behavior of a diagnosed cancer, primarily for use in clinical trials. Approved projects will have access to the institute’s assay development and validation resources, including project management support.
When applying to CADP, investigators must define the intended clinical use for the assay for which support is requested and provide basic assay protocols. Assays submitted for CADP development services should have been tested on human tissue. Proposals will be reviewed for scientific merit, feasibility, and clinical importance.
Applications are due October 15. More information and the application are available online.

No hay comentarios:

Publicar un comentario